NAT1 and neoplasm: We found that negative NAT1 expression was positively correlated with several malignant clinicopathological parameters of GBC, including poorly differentiated type, larger tumor size (>3 cm), lymph node metastasis, invasion, advanced TNM stage, which is consistent with other reports (26).